Endowment / Foundation

Updated:

King's Fund

The King's Fund was established in 1897 as the Prince of Wales's Hospital Fund for London, created to raise money for voluntary hospitals.

King's Fund

The King's Fund was established in 1897 as the Prince of Wales's Hospital Fund for London, created to raise money for voluntary hospitals. Today it operates under a royal charter granted in 2008, with HM King Charles III as its President since 1986. The Fund is not a grantmaker in the passive sense — it commands an investment portfolio whose returns underpin its ability to publish, convene, and shape England's health and care policy landscape. The endowment deploys across at least three asset classes: private equity, infrastructure, and real estate. The real estate holdings include 11–13 Cavendish Square in Marylebone — the Fund's headquarters — plus commercial space at 7–10 Dean's Mews and land in Old Basing, Hampshire. On the infrastructure side, the portfolio has a global footprint. The Fund's private-equity exposure is concentrated in the United Kingdom. Instead of operating as a pure grantmaking foundation, it runs a co-investment and partnership model with entities like the Nuffield Trust and The Health Foundation on research projects, while also maintaining corporate relationships — GlaxoSmithKline (GSK) was a named partner for its GSK IMPACT Awards program. The leadership sits with CEO Sarah Woolnough and Chair of the Board of Trustees Rt Hon Professor Lord Kakkar. The Fund also runs a Corporate Partners and Supporters program, which functions as a professional network for businesses to engage in health-policy debate. This structure — blending an investment portfolio, a real-estate book, and a corporate-partnership network — sits alongside its core output of health-services research and policy advocacy. What distinguishes the King's Fund structurally is that it is not a family office, nor a typical private foundation with a spending-rule mandate. It is a royally chartered endowment that acts as a think-tank and convening body, using its own balance sheet — not just donated grant capital — to fund its operations and maintain independence. The investment function does not exist solely to generate returns for external distributions; it directly sustains the organization's permanent staff, London premises, and policy agenda.

General information

Firm type

Endowment / Foundation

Year founded

1897

AUM

$200M - $250M (Altss estimate)

Location

Region

Europe

Country

United Kingdom

City

London

Corporate office

11-13 Cavendish Square, London, W1G 0AN, UK

Principals

Sarah Woolnough

Chief Executive Officer

Rt Hon Professor Lord Kakkar

Chair of the Board of Trustees

Sector focus

Healthcare ServicesPrivate EquityInfrastructureReal Estate

Frequently asked questions

Who sets investment strategy at the King's Fund?

The ultimate governance rests with the Board of Trustees, chaired by Rt Hon Professor Lord Kakkar. Day-to-day leadership sits with CEO Sarah Woolnough. The Fund has not publicly named a dedicated CIO or head of investments, but its disclosed asset-class mix — private equity, infrastructure, and real estate — suggests a committee or trustee-level investment function directing manager selection and asset allocation.

What is the Fund's actual financial scale?

The King's Fund does not publicly disclose its total assets under management. Altss research estimates the endowment's portfolio in the range of $200 million to $250 million, derived from its known real estate footprint, global infrastructure commitments, and UK-focused private equity holdings. This estimate has not been confirmed by the Fund.

Is the King's Fund a family office or a foundation?

It is neither in the conventional sense. The King's Fund is a charitable endowment incorporated by royal charter, not a family office managing private wealth. It does not act as a passive grantmaker either — it runs an active investment portfolio whose returns directly fund its policy research, convening, and advocacy work on health and care in England.

Does the King's Fund co-invest with other institutions?

The Fund maintains documented research and policy partnerships — notably with the Nuffield Trust and The Health Foundation — but it has not disclosed co-investment relationships in its underlying private-equity or infrastructure portfolios. Its Corporate Partners and Supporters program suggests a preference for reputation- and influence-sharing over pooled investment vehicles with external entities.

What is the relationship between HM King Charles III and the King's Fund?

HM King Charles III has served as President of the King's Fund since 1986, when he was Prince of Wales. The Fund was originally founded in 1897 as the Prince of Wales's Hospital Fund for London. His role is ceremonial and ambassadorial; he is noted as a donor, but operational control rests with the CEO and Board of Trustees.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on family offices?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo